News
Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent ...
Trial Supports Subcutaneous Isatuximab as Effective Alternative to IV Version: Xavier Leleu, MD, PhD
The phase 3 IRAKLIA trial found that subcutaneous isatuximab delivered via an on-body system was as effective and safe as intravenous (IV) administration in relapsed/refractory multiple myeloma, ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") and Vertex Pharmaceuticals Incorporated (Headquarters: Boston, MA, U.S.; CEO: Reshma Kewalramani, M.D ...
Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical ...
In cancer care, accurate tools for predicting whether a tumor will spread (metastasize) can help patients receive the most ...
Tissue samples from 54 additional patients at various BOS stages were also evaluated for polymeric Ig receptor (pIgR) expression and subepithelial IgA-producing B-cell presence. S-IgA levels in BALF ...
Djokovic returns to Roland-Garros with a 6-3, 6-3, 6-3 victory over former UCLA player Mackie McDonald on a windy and rainy day. Coco Gauff also wins, but 2021 U.S. Open champion Daniil Medvedev ...
Monomeric IgA (M-IgA) is predominantly present in serum, whereas secretory IgA (S-IgA) is the most prevalent in mucous secretions. S-IgA comprises two IgA units and one J-chain, which are synthesized ...
Elevated levels of antigen-specific IgA and IgG responses were detected in serum from the immunized mice, consistent with a prior study demonstrating that intranasal vaccinations induce both nasal and ...
Pietro A. Canetta, MD, MS, reflects on a particularly impactful case involving a young professional with IgA nephropathy, who was diagnosed after showing mild proteinuria and hematuria. Despite a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results